In the breast cancer cell line, MCF-7, a novel STIM1-independent mechanism for triggering Ca2+ entry through Orai1 activation via the accessory protein Secretory Pathway Ca2+-ATPase 2 (SPCA2) has been identified [278]. This evidence concerns the gene ATP2C2 and breast cancer.